Long survivors unknown primary of the neck  by Gil, C.
reports of practical oncology and radiotherapy 1 8 ( 2 0 1 3 ) S198–S207 S203
Long survivors unknown primary of the neck
C. Gil
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We describe a case of a 53 year-old woman with personal history of strong smoking; the patient was presented with a right
lateral tumor of the cervical region with progressive growth, intermittent, painless and dysphonia of 5 months of evolution.
The head and neck CT showed a lesion of 3 cm×2 cm in the right level II without an evident primary tumor. The PET showed a
right cervical uptake and also in the 7th right rib. The extension study was negative. Fine-needle aspiration of the lymph node
was positive. The patient was underwent to a radical cervical right dissection, histologically was metastasis of squamous cell
carcinoma in 1/16 nodes with extracapsular extension. With the diagnostic of an unknown primary of the neck TxN2aM1 the
oncology group decide concomitant treatment with CDDP chemotherapy and local radiotherapy in the nasopharynx, oropharynx
and pharyngeal wall with 60Gy, boost up to 66Gy in right levels IB-IV, 55Gy in contralateral nodes and 50Gy in supraclavicular
nodes. Three months later the control PET was negative and we decided expectant treatment of the rib. The patient was in
regular follow-up by 38months when she began with rib pain, the PET had a greater increase uptake in the 7th right rib and she
was underwent to a resection of the 7th and 8th right ribs. Histologically was a poorly differentiated carcinoma of large cell size
with free edges. The tumor cells were nonspeciﬁc immunoreactive. The patient was not given adjuvant treatment post surgery.
The patient is in regular follow-up since the last 56 months with a complete response, 85 months after the ﬁrst diagnostic. At
the present, the patient is asymptomatic, the TC and PET revealed no recurrence tumor.
http://dx.doi.org/10.1016/j.rpor.2013.03.165
Long-term remission of a laryngeal carcinoma in second relapse with reirradiation and concurrent cisplatin
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I report the case of a patient with laryngeal carcinoma in second relapse and long term survivor for eleven years. The last of the
recurrences was reirradiated seven years ago with concurrent cisplatin, obtaining a maintained complete remission. This is a
77 year old male who underwent left frontolateral laryngectomy in July 2002 after a diagnosis of well differentiated squamous
cell carcinoma of the glottic larynx (pT1N0M0). As the superior surgical margin was involved, the patient received postoperative
radiotherapy. The ﬁelds covered the surgical bed and 66Gy/33frwere delivered. Twenty-sixmonths later he underwent surgery for
the second time. A total laryngectomyand right jugular neckdissectionwere performeddue to a local relapse involving vocal cord,
ventricle, false cord and thryoid cartilage (pT4aN0). All surgical margins were microscopically negative. A new recurrence was
detected in June 2005 presenting as a right paratracheal tumor with ﬁstulization. The mass had 4 cm in his largest dimension and
was adjacent to the tracheostomy, invading the right thyroid lobe. The treatment decision was made by the multidisciplinary
committee of laryngeal tumors. They selected reirradiation combined with cisplatin as the best alternative and the patient
received 3D-CRT, 60Gy/30 fr to the gross disease PTV, and concomitant cisplatin, 20mg/m2/day (120-h continuous infusion) in
the ﬁrst and ﬁfth weeks of radiation. A complete response of disease was achieved. Today, he remains progression free. I want
to highlight: (1) the high effectiveness of the enhanced reirradiation in this challenging situation – an extensive second local
relapse of a laryngeal cancer; (2) that the local complete response obtained has translated into a long term disease free status
and (3) the low late toxicity, in that case, for this salvage therapy.
http://dx.doi.org/10.1016/j.rpor.2013.03.166
Orbital lymphoma: Case report
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Orbital lymphoma refers to a lymphoma occurring in the conjunctiva, lacrimal gland, eyelid and ocular musculature. Primary
non-Hodgkin’s lymphoma (NLH) of the orbit is a rare presentation (8–10% of extranodal NLH). Majority of the orbital lymphoma
are of low grade variety and only 16% are of high-grade histology. The presenting age ranges from 15 to 70 years but majority of
them occur around 60 years of age. The commonest manifestation of the disease is a palpable mass followed by eye irritation,
ptosis, proptosis, excessive tearing, blurry vision, and pain. Orbital irradiation gets a local control rate of 83 to 100% and a ﬁve-year
disease-free survival of 62–100% for low grade lymphoma. Case report: Male, 35 years old, who referred exophthalmos in the right
eye since December of 1986. A scan showed an increase in size of the right eye muscles, classiﬁed as a probable pseudo-tumour.
A biopsy revealed the diagnostic of lymphoma. The patient was treated with chemotherapy (CT) with a partial response, so he
received radiotherapy (RT), 40Gy over orbit area, obtaining a complete response. A new lymphoma appeared in the left eye, eight
years later. The patient was treated again with QT without obtaining response, so radiotherapy was administered on that new
lesion (same dose). To date, the patient remains in complete remission. He only has bilateral eye cataracts.
http://dx.doi.org/10.1016/j.rpor.2013.03.167
